Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28330169 | 0.90 | ALOX15 (0.38) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL4032761 | 0.85 | ALOX15 (0.44) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL27916807 | 0.83 | KMT2A (0.35) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL11133657 | 0.83 | ALOX15 (0.42) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL11222164 | 0.82 | KMT2A (0.50) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL11222161 | 0.82 | KMT2A (0.50) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL23878704 | 0.81 | KMT2A (0.42) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL29140275 | 0.81 | ALOX15 (0.42) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL4299640 | 0.77 | GSR (0.48) | ALOX15BLMKMT2A | |
| SCHEMBL4299915 | 0.77 | GSR (0.48) | ALOX15BLMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107857795-A | The preparation method of glycylglutamine impurity | 山东齐都药业有限公司 | 2018-03-30 | — | — | CN | disclosed |
| US-20090176743-A1 | Methods for treating or preventing reactivation of a latent herpesvirus infection | BETH ISRAEL DEACONESS MEDICAL CENTER | 2009-07-09 | — | — | US | disclosed |
| WO-2007016450-A2 | METHODS FOR TREATING OR PREVENTING REACTIVATION OF A LATENT HERPESVIRUS INFECTION | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2007-02-08 | — | — | WO | disclosed |
| EP-0833644-B1 | PHARMACEUTICAL AND DIET FORMULATIONS FOR THE PROPHYLAXIS AND TREATMENT OF GASTROINTESTINAL DISORDERS | BRACCO SPA (IT) | 2003-03-19 | — | — | EP | disclosed |
| CN-1082373-C | Pharmaceutical and dietary preparation for preventing and treating gastrointestinal diseases | BRACCO SPA (IT) | 2002-04-10 | — | — | CN | disclosed |
| US-6007808-A | NUTRIENT MIXTURE OF EUBIOTIC BACTERIA AND GLUTAMINE OR GLUTAMINE-CONTAINING POLYPEPTIDE | DIBRA S.P.A. (IT) | 1999-12-28 | — | — | US | disclosed |
| CN-1188413-A | Pharmaceutical and diet formulations for prophylaxis and treatment of gastrointestinal disorders | BRACCO SPA (IT) | 1998-07-22 | — | — | CN | disclosed |
| EP-0833644-A1 | PHARMACEUTICAL AND DIET FORMULATIONS FOR THE PROPHYLAXIS AND TREATMENT OF GASTROINTESTINAL DISORDERS | BRACCO S.p.A. (IT) | 1998-04-08 | — | — | EP | disclosed |
| WO-1997000688-A1 | PHARMACEUTICAL AND DIET FORMULATIONS FOR THE PROPHYLAXIS AND TREATMENT OF GASTROINTESTINAL DISORDERS | BRACCO S.P.A. (IT) | 1997-01-09 | — | — | WO | disclosed |